STAAR Surgical Company (STAA) Market Cap & Valuation Ratios
STAAR Surgical Company (STAA) has a market cap of $1.1B and a price-to-sales ratio of 3.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
STAASTAAR Surgical CompanyFollow STAA — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
medical instruments & supplies · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| STAA | 1.1 | — | 2.8 | 42.8 | -0.6% | +51% | 4% | 6% |
| LMAT | 1.9 | 29.6 | 6.6 | 19.6 | 3.8% | +12% | 29% | 11% |
| XRAY | 1.9 | — | 1.1 | 99.1 | 7.6% | -0.8% | -9% | -8% |
| KMTS | 1.7 | — | 14.9 | — | -7.2% | +61% | -134% | -114% |
| AZTA | 1.6 | — | 2.1 | — | 0.6% | +5% | -29% | -13% |
| DRTS | 1.2 | — | — | — | -1.3% | — | — | -93% |
| AVR | 0.6 | — | 143.9 | — | — | -10% | — | — |
| ANGO | 0.5 | — | 1.5 | — | 0.3% | +8% | -11% | -27% |
| DCTH | 0.5 | — | 4.2 | — | 3.5% | +36% | -2% | -3% |
| SGHT | 0.5 | — | 5.4 | — | -4.7% | +9% | -33% | -736% |
| SSII | 0.5 | — | 8.3 | — | -4.0% | +106% | -16% | -24% |
| Median of these 10 | 29.6 | 5.4 | 59.4 | 0.3% | +9% | -14% | -24% |
; EV/Sales 2.8 vs. 5.4.
Growth vs. price
each dot a company · hover or tap for valuesSTAAR Surgical Company — questions
- What is STAAR Surgical Company's market cap?
- $1.1B.
- What is STAAR Surgical Company's price-to-sales ratio?
- 3.3.
Every figure on this page comes from STAAR Surgical Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.